Catalyst Wire Dossier Catalyst Wire Dossier

3-AP (Triapine)

3-aminopyridine-2-carboxaldehyde thiosemicarbazone
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 3-AP (Triapine), covering 2013-01-24 to 2017-08-18. Get the full timeline:

Most recent: Clinical Trial Update: 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1]

See pricing